Keyphrases
Direct Oral Anticoagulants
100%
Adrenergic Receptors
72%
Warfarin
70%
Dexmedetomidine
68%
Genotype
60%
Adrenoceptors
60%
CYP2C9
58%
Genetic Variation
58%
Polymorphism
55%
Confidence Interval
46%
ED50
36%
COVID-19
34%
White People
32%
Heart Rate
32%
Vasoconstriction
30%
Venoconstriction
30%
Systematic Meta-analysis
29%
Network Meta-analysis
29%
Nested Case-control Study
29%
Atrial Fibrillation
29%
Vascular Reactivity
29%
Healthy Individuals
25%
CYP2C9 Polymorphism
25%
Blood Pressure Response
25%
Metabolism
25%
ADRB1
25%
Blood Pressure
24%
CYP2C9 Genotype
24%
Israel
24%
Phenylephrine
24%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
92%
Adrenergic Receptor
70%
Warfarin
69%
Anticoagulant Agent
56%
Dexmedetomidine
51%
CYP2C9
49%
Case-Control Study
38%
Bleeding
34%
Diseases
31%
Atrial Fibrillation
30%
Adverse Event
29%
Pharmacokinetics
28%
Apixaban
26%
Cohort Study
23%
Observational Study
22%
Live Attenuated Influenza Vaccine
22%
Calcium Channel Blocker
22%
Rivaroxaban
20%
Normal Human
18%
Immunoglobulin A
17%
Adrenergic Receptor Stimulating Agent
17%
Coronavirinae
14%
Atenolol
14%
Lung Cancer
14%
Anticonvulsive Agent
14%
Methotrexate
14%
Carcinoid
14%
Acute Kidney Failure
14%
sodium glucose cotransporter-2 inhibitors
14%
Drug Interaction
13%